$6.46 Billion is the total value of Orbimed Advisors's 128 reported holdings in Q2 2019. The portfolio turnover from Q1 2019 to Q2 2019 was 32.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ASND | Sell | ASCENDIS PHARMA A Ssponsored adr | $442,944,000 | -5.2% | 3,846,673 | -3.1% | 6.86% | -5.2% |
| TCDA | Buy | TRICIDA INC | $438,569,000 | +4.3% | 11,114,280 | +2.1% | 6.79% | +4.3% |
| BSX | Buy | BOSTON SCIENTIFIC CORP | $290,222,000 | +30.6% | 6,752,500 | +16.6% | 4.50% | +30.7% |
| ALXN | Sell | ALEXION PHARMACEUTICALS INC | $252,279,000 | -4.6% | 1,926,085 | -1.6% | 3.91% | -4.6% |
| ALEC | ALECTOR INC | $250,464,000 | +1.5% | 13,182,329 | 0.0% | 3.88% | +1.5% | |
| MRK | MERCK & CO INC | $215,503,000 | +0.8% | 2,570,100 | 0.0% | 3.34% | +0.8% | |
| PRVL | New | PREVAIL THERAPEUTICS INC | $182,457,000 | – | 13,822,463 | +100.0% | 2.83% | – |
| VRTX | Buy | VERTEX PHARMACEUTICALS INC | $178,484,000 | +1.6% | 973,300 | +1.9% | 2.76% | +1.6% |
| NBIX | NEUROCRINE BIOSCIENCES INC | $154,777,000 | -4.2% | 1,833,200 | 0.0% | 2.40% | -4.1% | |
| IOVA | IOVANCE BIOTHERAPEUTICS INC | $136,045,000 | +157.8% | 5,548,326 | 0.0% | 2.11% | +157.9% | |
| TMO | Buy | THERMO FISHER SCIENTIFIC INC | $135,915,000 | +11.0% | 462,800 | +3.5% | 2.10% | +11.1% |
| EW | EDWARDS LIFESCIENCES CORP | $132,089,000 | -3.4% | 715,000 | 0.0% | 2.05% | -3.4% | |
| SRPT | SAREPTA THERAPEUTICS INC | $125,875,000 | +27.5% | 828,400 | 0.0% | 1.95% | +27.5% | |
| WMGI | WRIGHT MED GROUP N V | $124,880,000 | -5.2% | 4,187,799 | 0.0% | 1.93% | -5.1% | |
| ISRG | INTUITIVE SURGICAL INC | $110,313,000 | -8.1% | 210,300 | 0.0% | 1.71% | -8.1% | |
| TPTX | New | TURNING POINT THERAPEUTICS I | $104,499,000 | – | 2,567,550 | +100.0% | 1.62% | – |
| ANTM | Buy | ANTHEM INC | $102,047,000 | +9.3% | 361,600 | +11.2% | 1.58% | +9.3% |
| BHC | BAUSCH HEALTH COS INC | $94,340,000 | +2.1% | 3,740,700 | 0.0% | 1.46% | +2.2% | |
| PTCT | Buy | PTC THERAPEUTICS INC | $94,037,000 | +64.4% | 2,089,700 | +37.5% | 1.46% | +64.3% |
| INSP | INSPIRE MED SYS INC | $89,216,000 | +6.8% | 1,471,000 | 0.0% | 1.38% | +6.9% | |
| NTRA | Buy | NATERA INC | $88,927,000 | +300.2% | 3,224,328 | +199.2% | 1.38% | +300.3% |
| LOGC | LOGICBIO THERAPEUTICS INC | $84,068,000 | +31.6% | 6,466,783 | 0.0% | 1.30% | +31.6% | |
| EXEL | Buy | EXELIXIS INC | $83,619,000 | +25.4% | 3,912,900 | +39.7% | 1.30% | +25.5% |
| AVDR | AVEDRO INC | $83,276,000 | +60.1% | 4,240,128 | 0.0% | 1.29% | +60.2% | |
| DCPH | DECIPHERA PHARMACEUTICALS IN | $81,590,000 | -2.8% | 3,618,171 | 0.0% | 1.26% | -2.8% | |
| ABT | Buy | ABBOTT LABS | $78,886,000 | +60.4% | 938,000 | +52.4% | 1.22% | +60.4% |
| EHTH | Sell | EHEALTH INC | $78,335,000 | +6.4% | 909,814 | -23.0% | 1.21% | +6.4% |
| ATNX | Buy | ATHENEX INC | $76,035,000 | +1343.3% | 3,840,130 | +793.1% | 1.18% | +1336.6% |
| THOR | SYNTHORX INC | $71,824,000 | -33.7% | 5,316,355 | 0.0% | 1.11% | -33.7% | |
| QURE | New | UNIQURE NV | $70,163,000 | – | 897,800 | +100.0% | 1.09% | – |
| MGTX | Buy | MEIRAGTX HOLDINGS PLC | $69,537,000 | +64.0% | 2,586,951 | +5.1% | 1.08% | +64.2% |
| REGN | Buy | REGENERON PHARMACEUTICALS | $67,545,000 | -23.4% | 215,800 | +0.5% | 1.05% | -23.4% |
| A | Buy | AGILENT TECHNOLOGIES INC | $66,695,000 | +3.9% | 893,200 | +11.8% | 1.03% | +3.9% |
| BOLD | Sell | AUDENTES THERAPEUTICS INC | $64,857,000 | -8.4% | 1,713,069 | -5.6% | 1.00% | -8.4% |
| BMY | Buy | BRISTOL MYERS SQUIBB CO | $61,005,000 | +7.0% | 1,345,200 | +12.6% | 0.94% | +7.0% |
| ARVN | ARVINAS INC | $58,907,000 | +49.0% | 2,678,810 | 0.0% | 0.91% | +49.0% | |
| PRNB | Sell | PRINCIPIA BIOPHARMA INC | $53,294,000 | -39.8% | 1,605,713 | -38.4% | 0.82% | -39.8% |
| ILMN | Sell | ILLUMINA INC | $51,615,000 | -26.9% | 140,200 | -38.3% | 0.80% | -26.9% |
| CRNX | Buy | CRINETICS PHARMACEUTICALS IN | $50,982,000 | +17.0% | 2,039,282 | +6.5% | 0.79% | +17.2% |
| TORC | RESTORBIO INC | $49,270,000 | +49.6% | 4,830,387 | 0.0% | 0.76% | +49.6% | |
| MYOK | Buy | MYOKARDIA INC | $47,899,000 | +1.6% | 955,300 | +5.4% | 0.74% | +1.6% |
| APLS | Buy | APELLIS PHARMACEUTICALS INC | $46,213,000 | +34.5% | 1,823,700 | +3.5% | 0.72% | +34.6% |
| VRAY | VIEWRAY INC | $45,363,000 | +19.2% | 5,149,019 | 0.0% | 0.70% | +19.4% | |
| ARGX | Sell | ARGENX SEsponsored adr | $43,946,000 | -2.6% | 310,400 | -14.1% | 0.68% | -2.4% |
| ZLAB | Sell | ZAI LAB LTDadr | $40,763,000 | -1.4% | 1,169,000 | -16.6% | 0.63% | -1.4% |
| NXTC | New | NEXTCURE INC | $40,611,000 | – | 2,711,013 | +100.0% | 0.63% | – |
| CI | CIGNA CORP NEW | $39,797,000 | -2.0% | 252,600 | 0.0% | 0.62% | -2.1% | |
| DXCM | Buy | DEXCOM INC | $39,393,000 | +138.5% | 262,900 | +89.5% | 0.61% | +138.3% |
| TNDM | Sell | TANDEM DIABETES CARE INC | $36,827,000 | -8.1% | 570,790 | -9.6% | 0.57% | -8.2% |
| PRTA | Buy | PROTHENA CORP PLC | $32,400,000 | +9.7% | 3,065,278 | +25.9% | 0.50% | +9.8% |
| HARP | HARPOON THERAPEUTICS INC | $31,803,000 | +37.3% | 2,446,409 | 0.0% | 0.49% | +37.3% | |
| CDNA | CAREDX INC | $29,785,000 | +14.2% | 827,600 | 0.0% | 0.46% | +14.1% | |
| OBSV | OBSEVA SA | $29,469,000 | -11.6% | 2,605,531 | 0.0% | 0.46% | -11.6% | |
| SPY | Buy | SPDR S&P 500 ETF TRput | $29,300,000 | +107.4% | 100,000 | +100.0% | 0.45% | +107.3% |
| CLVS | Sell | CLOVIS ONCOLOGY INC | $28,450,000 | -59.5% | 1,913,234 | -32.4% | 0.44% | -59.5% |
| XTNT | XTANT MED HLDGS INC | $27,621,000 | -1.6% | 9,207,012 | 0.0% | 0.43% | -1.6% | |
| GILD | Sell | GILEAD SCIENCES INC | $27,132,000 | -6.0% | 401,600 | -9.5% | 0.42% | -6.0% |
| MYL | Sell | MYLAN N V | $26,148,000 | -81.0% | 1,373,305 | -71.8% | 0.40% | -81.0% |
| KRYS | Buy | KRYSTAL BIOTECH INC | $25,854,000 | +1227.2% | 642,006 | +984.3% | 0.40% | +1233.3% |
| ENDP | ENDO INTL PLC | $25,402,000 | -48.7% | 6,165,464 | 0.0% | 0.39% | -48.7% | |
| CRVS | Buy | CORVUS PHARMACEUTICALS INC | $24,556,000 | +2.4% | 6,565,685 | +10.0% | 0.38% | +2.4% |
| ADVM | Buy | ADVERUM BIOTECHNOLOGIES INC | $23,307,000 | +257.8% | 1,960,200 | +57.7% | 0.36% | +257.4% |
| AUPH | Buy | AURINIA PHARMACEUTICALS INC | $23,234,000 | +13.5% | 3,531,002 | +12.1% | 0.36% | +13.6% |
| BMY | New | BRISTOL MYERS SQUIBB COcall | $22,675,000 | – | 500,000 | +100.0% | 0.35% | – |
| ONCE | New | SPARK THERAPEUTICS INC | $22,513,000 | – | 219,900 | +100.0% | 0.35% | – |
| AMGN | AMGEN INC | $22,501,000 | -3.0% | 122,100 | 0.0% | 0.35% | -3.1% | |
| GNFT | Sell | GENFIT S Aads | $22,231,000 | -24.7% | 1,125,607 | -8.5% | 0.34% | -24.7% |
| KALA | KALA PHARMACEUTICALS INC | $21,997,000 | -22.9% | 3,447,840 | 0.0% | 0.34% | -22.7% | |
| ALC | New | ALCON INC | $21,682,000 | – | 351,380 | +100.0% | 0.34% | – |
| BIIB | BIOGEN INC | $20,510,000 | -1.1% | 87,700 | 0.0% | 0.32% | -0.9% | |
| SIBN | SI BONE INC | $20,042,000 | +8.0% | 985,368 | 0.0% | 0.31% | +8.0% | |
| KPTI | New | KARYOPHARM THERAPEUTICS INC | $18,859,000 | – | 3,148,475 | +100.0% | 0.29% | – |
| SYBX | SYNLOGIC INC | $18,473,000 | +19.9% | 2,029,996 | 0.0% | 0.29% | +19.7% | |
| TAK | TAKEDA PHARMACEUTICAL CO LTDcall | $17,700,000 | -13.1% | 1,000,000 | 0.0% | 0.27% | -13.0% | |
| RYTM | RHYTHM PHARMACEUTICALS INC | $17,321,000 | -19.7% | 787,300 | 0.0% | 0.27% | -19.8% | |
| VRCA | VERRICA PHARMACEUTICALS INC | $17,194,000 | +7.5% | 1,479,733 | 0.0% | 0.27% | +7.3% | |
| NVO | NOVO-NORDISK A Sadr | $16,843,000 | -2.4% | 330,000 | 0.0% | 0.26% | -2.2% | |
| SVA | SINOVAC BIOTECH LTD | $16,611,000 | -9.6% | 2,839,500 | 0.0% | 0.26% | -9.5% | |
| ALPN | ALPINE IMMUNE SCIENCES INC | $15,455,000 | -38.6% | 3,670,955 | 0.0% | 0.24% | -38.7% | |
| AGLE | AEGLEA BIOTHERAPEUTICS INC | $14,834,000 | -14.9% | 2,165,524 | 0.0% | 0.23% | -14.8% | |
| ABBV | New | ABBVIE INCcall | $14,544,000 | – | 200,000 | +100.0% | 0.22% | – |
| XFOR | Buy | X4 PHARMACEUTICALS INC | $14,047,000 | +159.0% | 936,493 | +200.6% | 0.22% | +159.5% |
| AMRN | Buy | AMARIN CORP PLCspons adr new | $13,914,000 | +43.3% | 717,600 | +53.5% | 0.22% | +43.3% |
| TAK | TAKEDA PHARMACEUTICAL CO LTDsponsored ads | $13,275,000 | -13.1% | 750,000 | 0.0% | 0.21% | -13.1% | |
| PRQR | Sell | PROQR THRAPEUTICS N V | $12,581,000 | -54.2% | 1,382,502 | -30.2% | 0.20% | -54.2% |
| FOMX | FOAMIX PHARMACEUTICALS LTD | $12,365,000 | -36.5% | 5,195,330 | 0.0% | 0.19% | -36.8% | |
| IMMU | Sell | IMMUNOMEDICS INC | $11,348,000 | -86.2% | 818,200 | -80.8% | 0.18% | -86.1% |
| NABRIVA THERAPEUTICS PLC | $11,286,000 | -0.4% | 4,644,600 | 0.0% | 0.18% | 0.0% | ||
| SYK | STRYKER CORP | $11,101,000 | +4.1% | 54,000 | 0.0% | 0.17% | +4.2% | |
| ARQL | New | ARQULE INC | $11,010,000 | – | 1,000,000 | +100.0% | 0.17% | – |
| PFE | New | PFIZER INCput | $10,830,000 | – | 250,000 | +100.0% | 0.17% | – |
| SCPH | SCPHARMACEUTICALS INC | $10,877,000 | +6.3% | 3,409,865 | 0.0% | 0.17% | +6.3% | |
| CNST | CONSTELLATION PHARMCETICLS I | $10,264,000 | -9.4% | 835,842 | 0.0% | 0.16% | -9.1% | |
| RETA | New | REATA PHARMACEUTICALS INCput | $9,435,000 | – | 100,000 | +100.0% | 0.15% | – |
| PSNL | New | PERSONALIS INC | $8,145,000 | – | 300,000 | +100.0% | 0.13% | – |
| PBYI | Sell | PUMA BIOTECHNOLOGY INC | $7,934,000 | -89.1% | 624,249 | -66.8% | 0.12% | -89.1% |
| MRSN | MERSANA THERAPEUTICS INC | $7,659,000 | -23.0% | 1,891,119 | 0.0% | 0.12% | -22.7% | |
| ASMB | Sell | ASSEMBLY BIOSCIENCES INC | $7,063,000 | -64.0% | 523,600 | -47.4% | 0.11% | -64.1% |
| GILD | New | GILEAD SCIENCES INCcall | $6,756,000 | – | 100,000 | +100.0% | 0.10% | – |
| FOLD | AMICUS THERAPEUTICS INC | $6,468,000 | -8.2% | 518,309 | 0.0% | 0.10% | -8.3% | |
| ARNA | New | ARENA PHARMACEUTICALS INC | $6,449,000 | – | 110,000 | +100.0% | 0.10% | – |
| VRNA | VERONA PHARMA PLCsponsored ads | $6,377,000 | -21.5% | 1,250,396 | 0.0% | 0.10% | -21.4% | |
| BMRN | Sell | BIOMARIN PHARMACEUTICAL INCput | $6,424,000 | -71.1% | 75,000 | -70.0% | 0.10% | -71.2% |
| BMRN | Sell | BIOMARIN PHARMACEUTICAL INC | $6,424,000 | -5.5% | 75,000 | -2.0% | 0.10% | -5.7% |
| XENE | XENON PHARMACEUTICALS INC | $6,259,000 | -3.0% | 634,812 | 0.0% | 0.10% | -3.0% | |
| ADPT | New | ADAPTIVE BIOTECHNOLOGIES COR | $5,796,000 | – | 120,000 | +100.0% | 0.09% | – |
| SPRO | SPERO THERAPEUTICS INC | $5,841,000 | -10.2% | 507,471 | 0.0% | 0.09% | -10.9% | |
| MDCO | New | MEDICINES CO | $5,526,000 | – | 151,515 | +100.0% | 0.09% | – |
| ADAP | ADAPTIMMUNE THERAPEUTICS PLCsponds adr | $5,430,000 | -6.5% | 1,350,655 | 0.0% | 0.08% | -6.7% | |
| NTLA | Sell | INTELLIA THERAPEUTICS INC | $5,363,000 | -16.8% | 327,600 | -13.2% | 0.08% | -17.0% |
| SELB | SELECTA BIOSCIENCES INC | $5,154,000 | -24.5% | 2,879,064 | 0.0% | 0.08% | -24.5% | |
| RARE | New | ULTRAGENYX PHARMACEUTICAL IN | $5,055,000 | – | 79,607 | +100.0% | 0.08% | – |
| ARPO | AERPIO PHARMACEUTICALS INC | $4,726,000 | +1.0% | 5,193,946 | 0.0% | 0.07% | +1.4% | |
| CTIC | CTI BIOPHARMA CORP | $4,297,000 | -11.4% | 5,000,000 | 0.0% | 0.07% | -10.7% | |
| MNLO | Buy | MENLO THERAPEUTICS INC | $4,035,000 | -18.9% | 673,700 | +6.3% | 0.06% | -19.5% |
| STOK | New | STOKE THERAPEUTICS INC | $3,792,000 | – | 130,000 | +100.0% | 0.06% | – |
| NVUS | Buy | NOVUS THERAPEUTICS INC | $3,215,000 | -68.5% | 3,183,314 | +25.5% | 0.05% | -68.4% |
| RLM | REALM THERAPEUTICS PLCsponsored ads | $2,870,000 | -27.0% | 1,021,484 | 0.0% | 0.04% | -27.9% | |
| ACAD | New | ACADIA PHARMACEUTICALS INC | $2,724,000 | – | 101,900 | +100.0% | 0.04% | – |
| DVAX | New | DYNAVAX TECHNOLOGIES CORP | $2,328,000 | – | 583,500 | +100.0% | 0.04% | – |
| SNDX | SYNDAX PHARMACEUTICALS INC | $1,974,000 | +77.4% | 212,000 | 0.0% | 0.03% | +82.4% | |
| APLS | APELLIS PHARMACEUTICALS INCcall | $1,901,000 | +29.9% | 75,000 | 0.0% | 0.03% | +26.1% | |
| AVRO | Sell | AVROBIO INC | $1,724,000 | -60.6% | 106,000 | -46.6% | 0.03% | -60.3% |
| MRNS | MARINUS PHARMACEUTICALS INC | $1,652,000 | -0.7% | 398,101 | 0.0% | 0.03% | 0.0% | |
| NVTRQ | NUVECTRA CORP | $1,173,000 | -69.6% | 350,000 | 0.0% | 0.02% | -70.0% | |
| FLXN | New | FLEXION THERAPEUTICS INC | $1,106,000 | – | 89,919 | +100.0% | 0.02% | – |
| BLRX | BIOLINERX LTDsponsored ads | $379,000 | -15.2% | 1,038,600 | 0.0% | 0.01% | -14.3% | |
| MDGS | MEDIGUS LTDsponsored ads | $37,000 | -15.9% | 15,000 | 0.0% | 0.00% | 0.0% | |
| REPH | Exit | RECRO PHARMA INC | $0 | – | -43,499 | -100.0% | -0.00% | – |
| SRRA | Exit | SIERRA ONCOLOGY INC | $0 | – | -317,104 | -100.0% | -0.01% | – |
| Exit | AEGERION PHARMACEUTICALS INCnote 2.000% 8/1 | $0 | – | -2,000,000 | -100.0% | -0.02% | – | |
| KALV | Exit | KALVISTA PHARMACEUTICALS INC | $0 | – | -90,500 | -100.0% | -0.04% | – |
| AERI | Exit | AERIE PHARMACEUTICALS INC | $0 | – | -58,000 | -100.0% | -0.04% | – |
| NVTA | Exit | INVITAE CORP | $0 | – | -222,017 | -100.0% | -0.08% | – |
| WVE | Exit | WAVE LIFE SCIENCES LTDput | $0 | – | -180,000 | -100.0% | -0.11% | – |
| AMRN | Exit | AMARIN CORP PLCcall | $0 | – | -350,000 | -100.0% | -0.11% | – |
| WMGI | Exit | WRIGHT MED GROUP N Vcall | $0 | – | -250,000 | -100.0% | -0.12% | – |
| ENTA | Exit | ENANTA PHARMACEUTICALS INC | $0 | – | -233,100 | -100.0% | -0.34% | – |
| CBAY | Exit | CYMABAY THERAPEUTICS INC | $0 | – | -1,874,955 | -100.0% | -0.38% | – |
| HRTX | Exit | HERON THERAPEUTICS INC | $0 | – | -1,069,000 | -100.0% | -0.40% | – |
| CELG | Exit | CELGENE CORP | $0 | – | -295,000 | -100.0% | -0.43% | – |
| BGNE | Exit | BEIGENE LTDsponsored adr | $0 | – | -282,500 | -100.0% | -0.58% | – |
| HUM | Exit | HUMANA INC | $0 | – | -210,300 | -100.0% | -0.87% | – |
| TEVA | Exit | TEVA PHARMACEUTICAL INDS LTDsponsored ads | $0 | – | -4,079,000 | -100.0% | -0.99% | – |
| GH | Exit | GUARDANT HEALTH INC | $0 | – | -1,534,464 | -100.0% | -1.82% | – |
| CMTA | Exit | CLEMENTIA PHARMACEUTICALS IN | $0 | – | -10,425,225 | -100.0% | -4.21% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-08-14
About Orbimed Advisors
Orbimed Advisors is a leading healthcare-focused investment firm that manages over $16 billion in assets. The firm was founded in 1998 by Samuel Isaly, who has over 50 years of experience in the healthcare industry. Isaly is widely regarded as a pioneer in the field of healthcare investing and has been recognized for his contributions to the industry by numerous organizations.
Orbimed Advisors has a team of over 100 professionals, including investment professionals, research analysts, and operational experts. The firm has offices in New York, San Francisco, Shanghai, and Mumbai, and invests in companies across the healthcare spectrum, including biotechnology, pharmaceuticals, medical devices, and healthcare services.
The firm's investment philosophy is based on a deep understanding of the healthcare industry and a rigorous approach to due diligence. Orbimed Advisors seeks to identify companies with innovative technologies and strong management teams that have the potential to transform the healthcare landscape.
Orbimed Advisors has a strong track record of success, with numerous successful investments in companies such as Juno Therapeutics, Spark Therapeutics, and Kite Pharma. The firm's leadership team, which includes CEO Sven Borho, COO Jonathan Silverstein, and Chief Investment Officer Carl Gordon, has decades of experience in the healthcare industry and is widely respected for their expertise and insights.
Overall, Orbimed Advisors is a leading healthcare investment firm that has a proven track record of success and a deep understanding of the healthcare industry. Investors looking to gain exposure to the healthcare sector may want to consider Orbimed Advisors as a potential investment opportunity.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BIOGEN INC | 42 | Q3 2023 | 5.0% |
| VERTEX PHARMACEUTICALS INC | 42 | Q3 2023 | 3.7% |
| THERMO FISHER SCIENTIFIC INC | 42 | Q3 2023 | 3.2% |
| SINOVAC BIOTECH LTD | 41 | Q3 2023 | 7.2% |
| NEUROCRINE BIOSCIENCES INC | 41 | Q3 2023 | 2.7% |
| BOSTON SCIENTIFIC CORP | 40 | Q3 2023 | 5.6% |
| BRISTOL-MYERS SQUIBB CO | 40 | Q2 2023 | 5.2% |
| AMGEN INC | 40 | Q3 2023 | 5.5% |
| INTUITIVE SURGICAL INC | 40 | Q3 2023 | 3.8% |
| GILEAD SCIENCES INC | 39 | Q3 2023 | 5.5% |
View Orbimed Advisors's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Ikena Oncology, Inc. | September 21, 2023 | 2,189,111 | 5.2% |
| Galecto, Inc. | September 18, 2023 | 749,557 | 2.8% |
| PMV Pharmaceuticals, Inc. | August 23, 2023 | 6,563,077 | 13.5% |
| Gracell Biotechnologies Inc. | August 11, 2023 | 7,641,531 | 8.0% |
| Xtant Medical Holdings, Inc. | August 03, 2023 | 73,114,592 | 56.7% |
| Turnstone Biologics Corp. | July 24, 2023 | 3,099,265 | 13.4% |
| Prelude Therapeutics Inc | May 24, 2023 | 15,716,642 | 28.6% |
| VectivBio Holding AG | May 24, 2023 | 5,156,561 | 7.7% |
| Fusion Pharmaceuticals Inc. | May 16, 2023 | 2,930,670 | 4.6% |
| Verona Pharma plc | May 16, 2023 | 3,777,778 | 4.8% |
View Orbimed Advisors's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2024-04-26 |
| 4 | 2024-04-23 |
| 4 | 2024-04-18 |
| 4 | 2024-04-15 |
| 3/A | 2024-04-12 |
| SC 13D/A | 2024-04-12 |
| 4 | 2024-04-05 |
| SC 13D/A | 2024-04-04 |
| 3 | 2024-04-03 |
| SC 13D | 2024-03-28 |
View Orbimed Advisors's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.